1. Bray, F, Ferlay, J, Soerjomataram, I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin 2018; 68: 394–424.
Google Scholar | Crossref | Medline2. Chao, X, Song, X, Wu, H, et al. Selection of treatment regimens for recurrent cervical cancer. Front Oncol 2021; 11: 618485.
Google Scholar | Crossref | Medline3. Siegel, RL, Miller, KD, Fuchs, HE, et al. Cancer statistics, 2021. CA: Cancer J Clin 2021; 71: 7–33.
Google Scholar | Crossref | Medline4. Jariyal, H, Gupta, C, Bhat, VS, et al. Advancements in cancer stem cell isolation and characterization. Stem Cell Rev Rep 2019; 15: 755–773.
Google Scholar | Crossref | Medline5. Shen, S, Wang, G, Zhang, R, et al. Development and validation of an immune gene-set based prognostic signature in ovarian cancer. EBioMedicine 2019; 40: 318–326.
Google Scholar | Crossref | Medline6. Walcher, L, Kistenmacher, AK, Suo, H, et al. Cancer stem cells-origins and biomarkers: perspectives for targeted personalized therapies. Front Immunol 2020; 11: 1280.
Google Scholar | Crossref | Medline7. Yang, S, Wu, Y, Deng, Y, et al. Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitors. Oncoimmunology 2019; 8: e1659094.
Google Scholar | Crossref | Medline8. Xu, R, Yang, WT, Zheng, PS. Coexpression of B-lymphoma Moloney murine leukemia virus insertion region-1 and sex-determining region of Y chromosome-related high mobility group box-2 in cervical carcinogenesis. Hum Pathol 2013; 44: 208–217.
Google Scholar | Crossref | Medline9. Weina, K, Utikal, J. SOX2 And cancer: current research and its implications in the clinic. Clin Transl Med 2014; 3: 19.
Google Scholar | Crossref | Medline10. Liu, K, Lin, B, Zhao, M, et al. The multiple roles for Sox2 in stem cell maintenance and tumorigenesis. Cell Signal 2013; 25: 1264–1271.
Google Scholar | Crossref | Medline11. Moshi, JM, Hoogduin, KJ, Ummelen, M, et al. Switches of SOX17 and SOX2 expression in the development of squamous metaplasia and squamous intraepithelial lesions of the uterine cervix. Cancer Med 2020; 9: 6330–6343.
Google Scholar | Crossref | Medline12. Xu, R, Chen, L, Yang, WT. Aberrantly elevated Bmi1 promotes cervical cancer tumorigenicity and tumor sphere formation via enhanced transcriptional regulation of Sox2 genes. Oncol Rep 2019; 42: 688–696.
Google Scholar | Medline13. Huang, C, Lu, H, Li, J, et al. SOX2 Regulates radioresistance in cervical cancer via the hedgehog signaling pathway. Gynecol Oncol 2018; 151: 533–541.
Google Scholar | Crossref | Medline14. Hou, T, Zhang, W, Tong, C, et al. Putative stem cell markers in cervical squamous cell carcinoma are correlated with poor clinical outcome. BMC Cancer 2015; 15: 785.
Google Scholar | Crossref | Medline15. Kim, BW, Cho, H, Choi, CH, et al. Clinical significance of OCT4 and SOX2 protein expression in cervical cancer. BMC Cancer 2015; 15: 1015.
Google Scholar | Crossref | Medline16. Moher, D, Liberati, A, Tetzlaff, J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Br Med J 2009; 339: b2535.
Google Scholar | Crossref | Medline17. Stang, A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603–605.
Google Scholar | Crossref | Medline | ISI18. Zintzaras, E, Ioannidis, JP. HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics 2005; 21: 3672–3673.
Google Scholar | Crossref | Medline | ISI19. Egger, M, Davey Smith, G, Schneider, M, et al. Bias in meta-analysis detected by a simple, graphical test Br Med J 1997; 315: 629–634.
Google Scholar | Crossref | Medline20. Stewart, CJR, Crook, ML. Podoplanin and SOX2 expression in CIN 3-like squamous cell carcinoma of the cervix. Int J Gynecol Pathol 2018; 37: 59–67.
Google Scholar | Crossref | Medline21. Stewart, CJ, Crook, M. SOX2 Expression in cervical intraepithelial neoplasia grade 3 (CIN3) and superficially invasive (stage IA1) squamous carcinoma of the cervix. Int J Gynecol Pathol 2016; 35: 566–573.
Google Scholar | Crossref | Medline22. Chang, X, Zhang, J, Huang, C, et al. Sex-determining region Y-related high mobility group box (SOX)-2 is overexpressed in cervical squamous cell carcinoma and contributes cervical cancer cell migration and invasion in vitro. Tumour Biol 2015; 36: 7725–7733.
Google Scholar | Crossref | Medline23. Ji, J, Wei, X, Wang, Y. Embryonic stem cell markers Sox-2 and OCT4 expression and their correlation with WNT signal pathway in cervical squamous cell carcinoma. Int J Clin Exp Pathol 2014; 7: 2470–2476.
Google Scholar | Medline24. Shen, L, Huang, X, Xie, X, et al. High expression of SOX2 and OCT4 indicates radiation resistance and an independent negative prognosis in cervical squamous cell carcinoma. J Histochem Cytochem 2014; 62: 499–509.
Google Scholar | SAGE Journals25. Yang, Z, Pan, X, Gao, A, et al. Expression of Sox2 in cervical squamous cell carcinoma. J BUON 2014; 19: 203–206.
Google Scholar | Medline26. Cai, C, Tan, G, Yu, Q, et al. Expression of SOX2 in cervical intraepithelial neoplasia and cervical cancer and its clinical significance. Nan Fang Yi Ke Da Xue Xue Bao 2013; 33: 128–130.
Google Scholar | Medline27. Ji, J, Zheng, PS. Expression of Sox2 in human cervical carcinogenesis. Hum Pathol 2010; 41: 1438–1447.
Google Scholar | Crossref | Medline | ISI28. Wang, H, Cai, H, Li, S, et al. Expression of OCT4,SOX2 and Nanog and its significance in cervical cancer. Mod Oncol 2018; 26: 1906–1909.
Google Scholar29. Zhang, L, Wei, Z, Li, J, et al. Expressions of transcription factor Oct-4 and SOX-2 in cervical cancer tissue and their significances. J Jilin Unive (Med Ed) 2013; 39: 1252–1255.
Google Scholar30. Zhao, Z, Chen, Q, Wang, Z, et al. Expression of SOX2 in cervical cancer and clinical significance. Hainan Med J 2016; 27: 2939–2942.
Google Scholar31. Balasubramaniam, SD, Balakrishnan, V, Oon, CE, et al. Key molecular events in cervical cancer development. Medicina (Kaunas) 2019; 55: 384. doi:10.3390/medicina55070384
Google Scholar | Crossref | Medline32. Rachmadi, L, Siregar, NC, Kanoko, M, et al. Role of cancer stem cell, apoptotic factor, DNA repair, and telomerase toward radiation therapy response in stage IIIB cervical cancer. Oman Med J 2019; 34: 224–230.
Google Scholar | Crossref | Medline33. Sudhalkar, N, Rathod, NP, Mathews, A, et al. Potential role of cancer stem cells as biomarkers and therapeutic targets in cervical cancer. Cancer Rep (Hoboken) 2019; 2: e1144.
Google Scholar | Crossref | Medline34. Chaudhary, S, Islam, Z, Mishra, V, et al. Sox2: a regulatory factor in tumorigenesis and metastasis. Curr Protein Pept Sci 2019; 20: 495–504.
Google Scholar | Crossref | Medline35. Zhang, XH, Wang, W, Wang, YQ, et al. The association of SOX2 with clinical features and prognosis in colorectal cancer: a meta-analysis. Pathol Res Pract 2020; 216: 152769.
Google Scholar | Crossref | Medline36. Li, W, Li, B, Wang, R, et al. SOX2 As prognostic factor in head and neck cancer: a systematic review and meta-analysis. Acta Otolaryngol 2014; 134: 1101–1108.
Google Scholar | Crossref | Medline